載入...
A critical appraisal of ibrutinib in the treatment of mantle cell lymphoma and chronic lymphocytic leukemia
Although chemo-immunotherapy remains at the forefront of first-line treatment for mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL), small molecules, such as ibrutinib, are beginning to play a significant role, particularly in patients with multiply relapsed or chemotherapy-refractor...
Na minha lista:
| 發表在: | Ther Clin Risk Manag |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4484687/ https://ncbi.nlm.nih.gov/pubmed/26150724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S73559 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|